Allogeneic stem cell transplant in myelodysplastic syndrome‐factors impacting survival

European Journal Of Haematology ◽

10.1111/ejh.13353 ◽

2019 ◽

Vol 104 (2) ◽

pp. 116-124 ◽

Author(s):

Shruti Prem ◽

Eshetu G. Atenafu ◽

Wilson Lam ◽

Arjun Law ◽

Fotios V. Michelis ◽

...

Keyword(s):

Stem Cell ◽

Myelodysplastic Syndrome ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant

Download Full-text

THE SFGM-TC MDS SCORE AT DAY 180 IS ASSOCIATED WITH POST-TRANSPLANT OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WHO UNDERWENT CD34+ SELECTED ALLOGENEIC STEM CELL TRANSPLANT

10.1097/02014419-201906001-00444 ◽

2019 ◽

Vol 3 ◽

pp. 225

Author(s):

A. Alarcon ◽

S. Devlin ◽

M. Maloy ◽

J. D. Ruiz ◽

Sanchez M. Escamilla ◽

...

Keyword(s):

Stem Cell ◽

Myelodysplastic Syndrome ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Post Transplant ◽

Transplant Outcomes

Download Full-text

Successful Pregnancy after Extensive Graft-Versus-Host Disease Following Matched-Related Donor Allogeneic Stem Cell Transplant for Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.12.400 ◽

2017 ◽

Vol 23 (3) ◽

pp. S226

Author(s):

Lauren E. Lee ◽

Michael B. Osswald

Keyword(s):

Stem Cell ◽

Myelodysplastic Syndrome ◽

Graft Versus Host Disease ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Successful Pregnancy ◽

Host Disease ◽

Graft Versus Host ◽

Download Full-text

First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review

World Journal of Oncology ◽

10.14740/wjon1263 ◽

2020 ◽

Vol 11 (3) ◽

pp. 112-115

Author(s):

Mindy Hsiao ◽

Sergei Tatishchev ◽

Tarek Khedro ◽

Bassam Yaghmour ◽

Casey O’Connell ◽

...

Keyword(s):

Stem Cell ◽

Literature Review ◽

Myelodysplastic Syndrome ◽

Graft Versus Host Disease ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

First Report ◽

Graft Versus Host ◽

Download Full-text

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.03.023 ◽

2016 ◽

Vol 22 (7) ◽

pp. 1324-1329 ◽

Author(s):

Ibraheem H. Motabi ◽

Armin Ghobadi ◽

Jingxia Liu ◽

Mark Schroeder ◽

Camille N. Abboud ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Hypomethylating Agents ◽

Allogeneic Stem Cell Transplant ◽

Relapsed Acute Myeloid Leukemia ◽

Download Full-text

Phase I Trial of Post Allogeneic Stem Cell Transplant Maintenance Lenalidomide in Patients with High Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.376 ◽

2018 ◽

Vol 24 (3) ◽

pp. S322

Author(s):

Rajeev Krishnan ◽

Avan Lo ◽

Joseph Tuscano ◽

Carol Richman ◽

Mehrdad Abedi

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Phase I Trial ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Download Full-text

PF546 THE SFGM-TC MDS SCORE AT DAY 180 IS ASSOCIATED WITH POST-TRANSPLANT OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WHO UNDERWENT CD34+ SELECTED ALLOGENEIC STEM CELL TRANSPLANT

10.1097/01.hs9.0000560280.92775.52 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 225

Author(s):

A. Alarcon ◽

S. Devlin ◽

M. Maloy ◽

J.D. Ruiz ◽

M. Sanchez Escamilla ◽

...

Keyword(s):

Stem Cell ◽

Myelodysplastic Syndrome ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Post Transplant ◽

Transplant Outcomes

Download Full-text

Outcome of Patients with Myelodysplastic Syndrome and a Monosomal Karyotype Following Allogeneic Stem Cell Transplant: Single Institution Experience

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.778 ◽

2018 ◽

Vol 24 (3) ◽

pp. S239

Author(s):

Salwa S. Saadeh ◽

Omar Alkharabsheh ◽

Aref Al-Kali ◽

Mrinal M. Patnaik ◽

Mithun Vinod Shah ◽

...

Keyword(s):

Stem Cell ◽

Myelodysplastic Syndrome ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Single Institution ◽

Monosomal Karyotype

Download Full-text

HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations

Zeitschrift für Gastroenterologie ◽

10.1055/s-0037-1612891 ◽

2018 ◽

Vol 56 (01) ◽

pp. E2-E89 ◽

Author(s):

O Anastasiou ◽

F Almpani ◽

A Herrmann ◽

G Gerken ◽

M Ditschkowski ◽

...

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplant ◽

Hbv Reactivation ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Transplant Recipients

Download Full-text

Management of Allogeneic Stem Cell Transplant Recipients with Hepatic Veno-Occlusive Disease

Global Journal of Hematology and Blood Transfusion ◽

10.15379/2408-9877.2017.04.01.01 ◽

2017 ◽

Vol 4 (1) ◽

Author(s):

Alessandro Busca

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Occlusive Disease ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Transplant Recipients

Download Full-text

APR-246 in Combination With Azacitidine for TP53 Mutated AML or MDS Following Allogeneic Stem Cell Transplant

Case Medical Research ◽

10.31525/ct1-nct03931291 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant

Download Full-text